Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr
Chemical

Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr

The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.

  • By ICN Bureau | July 28, 2021

Dr. Reddy's Laboratories has reported total income of Rs.5053 crores during the period ended June 30, 2021 as compared to Rs.4850.8 crores during the period ended March 31, 2021.

The company reported total income of Rs.4513.6 crores during the period ended June 30, 2020.

Dr. Reddy's Laboratories has posted net profit of Rs.380.4 crores for the period ended June 30, 2021 as against net profit of Rs.557.3 crores for the period ended March 31, 2021.

The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.

Commenting on the results, G V Prasad, Co-Chairman & MD said "The financial performance of the quarter has been driven by healthy sales growth. I am confident about improving our margins in the upcoming quarters which will be led by the scale up of recent launches, new product launches and productivity. While we continue to sharpen execution in our core business, we are also conducting pilots in areas such as Nutrition, Di tamer, and Digital Health & Wellness, which can be future growth drivers."


Register Now to Attend AVEVA Industry 4.0 & Digitalization in Chemicals on Wednesday, 13th March 2024, Hotel Hyatt Place, Bharuch, Gujarat

Other Related stories

Startups

Petrochemical

Energy

Digitization